Ray Co., Ltd. (228670.KQ)

KRW 6250.0

(-2.5%)

Gross Profit Summary of Ray Co., Ltd.

Ray Co., Ltd.'s latest annual gross profit in 2023 was 65.08 Billion KRW , up 10.1% from previous year.
Ray Co., Ltd.'s latest quarterly gross profit in 2024 Q2 was 9.9 Billion KRW , up 67.06% from previous quarter.
Ray Co., Ltd. reported a annual gross profit of 59.11 Billion KRW in annual gross profit 2022, up 100.69% from previous year.
Ray Co., Ltd. reported a annual gross profit of 29.45 Billion KRW in annual gross profit 2021, up 20.44% from previous year.
Ray Co., Ltd. reported a quarterly gross profit of 9.9 Billion KRW for 2024 Q2, up 67.06% from previous quarter.
Ray Co., Ltd. reported a quarterly gross profit of 16.77 Billion KRW for 2023 Q3, down -11.75% from previous quarter.

Annual Gross Profit Chart of Ray Co., Ltd. (2023 - 2017)

Historical Annual Gross Profit of Ray Co., Ltd. (2023 - 2017)

Year	Gross Profit	Gross Profit Growth
2023	65.08 Billion KRW	10.1%
2022	59.11 Billion KRW	100.69%
2021	29.45 Billion KRW	20.44%
2020	24.45 Billion KRW	-26.78%
2019	33.4 Billion KRW	50.08%
2018	22.25 Billion KRW	51.31%
2017	14.7 Billion KRW	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q1	6.86 Billion KRW	-65.8%
2024 Q2	9.9 Billion KRW	67.06%
2023 Q3	16.77 Billion KRW	-11.75%
2023 Q4	20.06 Billion KRW	19.6%
2023 FY	65.08 Billion KRW	10.1%
2023 Q2	19 Billion KRW	105.69%
2023 Q1	9.24 Billion KRW	-58.97%
2022 Q2	13.33 Billion KRW	79.11%
2022 FY	59.11 Billion KRW	100.69%
2022 Q4	22.52 Billion KRW	42.42%
2022 Q3	15.81 Billion KRW	18.56%
2022 Q1	7.44 Billion KRW	237.92%
2021 FY	29.45 Billion KRW	20.44%
2021 Q4	2.2 Billion KRW	-79.21%
2021 Q3	10.6 Billion KRW	0.0%
2020 FY	24.45 Billion KRW	-26.78%
2019 FY	33.4 Billion KRW	50.08%
2018 FY	22.25 Billion KRW	51.31%
2017 FY	14.7 Billion KRW	0.0%

Peer Gross Profit Comparison of Ray Co., Ltd.

Name	Gross Profit	Gross Profit Difference
Osang Healthcare Co.,Ltd	219.75 Billion KRW	70.382%
InBody Co.,Ltd	128.11 Billion KRW	49.195%
Curexo Inc.	17.95 Billion KRW	-262.481%
Seegene, Inc.	180.07 Billion KRW	63.854%
i-SENS, Inc.	101.04 Billion KRW	35.583%
Gencurix Inc.	422.03 Million KRW	-15322.532%
Sugentech Inc.	-5.88 Billion KRW	1206.779%
L&C Bio Co., Ltd	32.52 Billion KRW	-100.103%